Skip to main content
. 2017 Dec 13;7:17487. doi: 10.1038/s41598-017-17832-x

Figure 2.

Figure 2

Hsp90 inhibition decreases oxidative and glycolytic metabolism in Her2-overexpressing and triple negative breast cancer. A seahorse extracellular flux analyzer was used to determine the baseline and post-treatment metabolic properties of BT-474, MCF-7, and MDA-MB-231 cells. The endpoints monitored were oxygen consumption rate (OCR, left column) and extracellular acidification rate (ECAR, right column). (a) Baseline OCR for each cell line. (b) Baseline ECAR for each cell line. (c) OCR or (d) ECAR for each cell line after 12, 24, or 48-hour treatment with 100 µM HS-27 or DMSO (vehicle). (e) MDA-MB-231, MCF-7, and BT-474 cells were plated at uniform density and treated with either 100 µM HS-27 or DMSO control for 48 hours. ANOVA with Tukey-Kramer post hoc testing (n = 6) was used for (a) and (b), while two-sided t-tests (n = 6) were used for (c) and (d) (n = 3) for (e).